References:
  1. Cohn SL, Pearson ADJ, London WB, et al. The International Neuroblastoma Risk Group (INRG) classification system: An INRG task force report. J Clin Oncol 2009; 27:289-297.
  2. Monclair T, Brodeur GM, Ambros PF, et al. The International Neuroblastoma Risk Group (INRG) staging system: An INRG Task Force report. J Clin Oncol 2009; 27:298-303.
  3. Major A, Cox SM, and Volchenboum SL. Using big data in pediatric oncology: current applications and future directions. Seminars in Oncology 2020; 47:56-64.
  4. Morris CD, Tunn P-U, Rodeberg DA, et al. Surgical management of extremity site rhabdomyosarcoma: a consensus opinion document from the Children’s Oncology Group, European Pediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe. Pediatric Blood and Cancer 2020; e28608.
  5. Lautz TB, Martelli H, Fuchs J, et al. Local treatment of rhabdomyosarcoma of the female genital tract: Expert consensus from the Children’s Oncology Group (COG), European Soft Tissue Sarcoma Group (EpSSG), and the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatric Blood and Cancer 2020; e28601.